News & Stories

See the latest news about CMT drug development and read stories from the CMT community that highlight why we must deliver treatments and cures during our lifetime.

CMTRF Inks Milestone-Driven Partnership with AcuraStem to Repurpose Established Drugs for the Treatment of CMT

Dec 20, 2018 | CMTRF Funded Research, Research News

Focus will be on expansion of AcuraStem’s patient-based discovery platform, iNeuroRx™, to leverage patient neurons and advanced informatics technology to identify promising drugs ATLANTA (December 20, 2018) The newly launched CMT Research Foundation (CMTRF), a...

Fontan Surgery for Heart Defects May Not Be Advisable for CMT1A Patients, Case Study Finds

Nov 19, 2018 | CMT Research Updates, Research News

Charcot-Marie-Tooth News reports the findings of a study where patients with Charcot-Marie-Tooth disease (CMT) who undergo Fontan surgery to correct a heart defect in childhood may later develop difficulties with the diaphragm — the muscle that allows us to breath —...

Where We Started, How Far We Have Come and Where We are Going

Nov 15, 2018 | Press Releases, Research News

The CMT Research Foundation offers hope to those living with CMT that a treatment and cure are on their way!

$1,000,000 pledge to CMT research

Nov 8, 2018 | Press Releases, Research News

CMTRF Receives $1 Million Research Grant from Grandview Steers Foundation The pace of research for CMT just got faster. Atlanta (November 8, 2018) The newly launched CMT Research Foundation (CMTRF), the only 501(c)(3) not-for-profit organization focused solely on...